Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Blood group Rh(D) polypeptide is a critical erythrocyte membrane component responsible for defining one’s “Rh-positive” status via expression of the highly immunogenic D antigen. Its proper function depends on interaction with other related membrane proteins such as RhAG. While best known for its role in transfusion compatibility and maternal-fetal medicine due to antibody formation risks when absent/mismatched between donor-recipient pairs, it also contributes structurally/functionally to red cell integrity—possibly acting as an ammonia transporter within a larger multiprotein complex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood group Rh(D) polypeptide (RhD).